Close Menu

NEW YORK (GenomeWeb) – Comprehensive sequencing-based tumor profiling in high-risk pediatric cancer patients yields a clinically significant finding in the majority of cases, but only a few receive a matched drug as a result, according to a new study by researchers at Columbia University Medical Center.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.